Bacterial, fungal and protozoan carbonic anhydrases as drug targets

Bibliography

• Tibayrenc M, Ayala FJ. Reproductive clonality of pathogens: A perspective on pathogenic viruses, bacteria, fungi, and parasitic protozoa. Proc Natl Acad Sci USA 2012;109:E3305-13
   PubMed Web of Science ®Google Scholar
• Roux O, Cereghino R, Solano PJ, et al. Caterpillars and fungal pathogens: two co-occurring parasites of an ant-plant mutualism. PLoS One 2011;6:e20538
   PubMed Web of Science ®Google Scholar
• Joyce SA, Watson RJ, Clarke DJ. The regulation of pathogenicity and mutualism in Photorhabdus. Curr Opin Microbiol 2006;9:127-32
   PubMed Web of Science ®Google Scholar
• Soto W, Punke EB, Nishiguchi MK. Evolutionary perspectives in a mutualism of sepiolid squid and bioluminescent bacteria: combined usage of microbial experimental evolution and temporal population genetics. Evolution 2012;66:1308-21
   PubMed Web of Science ®Google Scholar
• Cardoso T, Ribeiro O, Aragao IC, et al. Additional risk factors for infection by multidrug-resistant pathogens in healthcare-associated infection: a large cohort study. BMC Infect Dis 2012;12:375
   PubMed Web of Science ®Google Scholar
• Eiros Bouza JM, Oteo Revuelta JA. Zoonotic infectious diseases. Enferm Infecc Microbiol Clin 2011;29:51-4
   PubMed Web of Science ®Google Scholar
• Slingenbergh JI, Gilbert M, de Balogh KI, et al. Ecological sources of zoonotic diseases. Rev Sci Tech 2004;23:467-84
   PubMed Web of Science ®Google Scholar
• Cox GM, Mukherjee J, Cole GT, et al. Urease as a virulence factor in experimental cryptococcosis. Infect Immun 2000;68:443-8
   PubMed Web of Science ®Google Scholar
• Cox GM, McDade HC, Chen SC, et al. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol 2001;39:166-75
   PubMed Web of Science ®Google Scholar
• Bostanci N, Belibasakis GN. Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen. FEMS Microbiol Lett 2012;333:1-9
   PubMed Web of Science ®Google Scholar
• Alp S. Putative virulence factors of Aspergillus species. Mikrobiyol Bul 2006;40:109-19
   PubMedGoogle Scholar
• Schaller M, Borelli C, Korting HC, et al. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 2005;48:365-77
   PubMed Web of Science ®Google Scholar
• Kronholm S, Capel P. Concentrations, loads, and yields of organic carbon in streams of agricultural watersheds. J Environ Qual 2012;41:1874-83
   PubMed Web of Science ®Google Scholar
• Wingate L, Ogee J, Cuntz M, et al. The impact of soil microorganisms on the global budget of delta18O in atmospheric CO2. Proc Natl Acad Sci USA 2009;106:22411-15
   PubMed Web of Science ®Google Scholar
• Freeman C, Kim SY, Lee SH, et al. Effects of elevated atmospheric CO2 concentrations on soil microorganisms. J Microbiol 2004;42:267-77
   PubMed Web of Science ®Google Scholar
• Johnson X, Alric J. Interaction between starch breakdown, acetate assimilation, and photosynthetic cyclic electron flow in Chlamydomonas reinhardtii. J Biol Chem 2012;287:26445-52
   PubMed Web of Science ®Google Scholar
• Tcherkez G, Boex-Fontvieille E, Mahe A, et al. Respiratory carbon fluxes in leaves. Curr Opin Plant Biol 2012;15:308-14
   PubMed Web of Science ®Google Scholar
• Casey JR. Why bicarbonate? Biochem Cell Biol 2006;84:930-9
   PubMed Web of Science ®Google Scholar
• Kozliak EI, Fuchs JA, Guilloton MB, et al. Role of bicarbonate/CO2 in the inhibition of Escherichia coli growth by cyanate. J Bacteriol 1995;177:3213-19
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168-81
   PubMed Web of Science ®Google Scholar
• Supuran CT, Casini A, Scozzafava A. Protease inhibitors of the sulfonamide type: anticancer, antiinflammatory, and antiviral agents. Med Res Rev 2003;23:535-58
   PubMed Web of Science ®Google Scholar
• Alterio V, Di Fiore A, D’Ambrosio K, et al. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 2012;112:4421-68
   PubMed Web of Science ®Google Scholar
• Vullo D, Del Prete S, Osman SM, et al. Sulfonamide inhibition studies of the gamma-carbonic anhydrase from the oral pathogen Porphyromonas gingivalis. Bioorg Med Chem Lett 2014;24:240-4
   PubMed Web of Science ®Google Scholar
• Nishimori I, Vullo D, Minakuchi T, et al. Anion inhibition studies of two new beta-carbonic anhydrases from the bacterial pathogen Legionella pneumophila. Bioorg Med Chem Lett 2014;24:1127-32
   PubMed Web of Science ®Google Scholar
• Del Prete S, De Luca V, Scozzafava A, et al. Biochemical properties of a new alpha-carbonic anhydrase from the human pathogenic bacterium, Vibrio cholerae. J Enzyme Inhib Med Chem 2014;29:23-7
   PubMed Web of Science ®Google Scholar
• Alafeefy AM, Abdel-Aziz HA, Vullo D, et al. Inhibition of carbonic anhydrases from the extremophilic bacteria Sulfurihydrogenibium yellostonense (SspCA) and S. azorense (SazCA) with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moieties. Bioorg Med Chem 2014;22:141-7
   PubMed Web of Science ®Google Scholar
• Vullo D, Sai Kumar RS, Scozzafava A, et al. Anion inhibition studies of a beta-carbonic anhydrase from Clostridium perfringens. Bioorg Med Chem Lett 2013;23:6706-10
   PubMed Web of Science ®Google Scholar
• Vullo D, De Luca V, Scozzafava A, et al. The extremo-alpha-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium azorense is highly inhibited by sulfonamides. Bioorg Med Chem 2013;21:4521-5
   PubMed Web of Science ®Google Scholar
• Luca VD, Vullo D, Scozzafava A, et al. An alpha-carbonic anhydrase from the thermophilic bacterium Sulphurihydrogenibium azorense is the fastest enzyme known for the CO2 hydration reaction. Bioorg Med Chem 2013;21:1465-9
   PubMed Web of Science ®Google Scholar
• Di Fiore A, Capasso C, De Luca V, et al. X-ray structure of the first `extremo-alpha-carbonic anhydrase’, a dimeric enzyme from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1. Acta Crystallogr D Biol Crystallogr 2013;69:1150-9
   PubMed Web of Science ®Google Scholar
• Del Prete S, Vullo D, De Luca V, et al. A highly catalytically active gamma-carbonic anhydrase from the pathogenic anaerobe Porphyromonas gingivalis and its inhibition profile with anions and small molecules. Bioorg Med Chem Lett 2013;23:4067-71
   PubMed Web of Science ®Google Scholar
• Del Prete S, De Luca V, Vullo D, et al. Biochemical characterization of the gamma-carbonic anhydrase from the oral pathogen Porphyromonas gingivalis, PgiCA. J Enzyme Inhib Med Chem 2014;29(4):532-7
   PubMed Web of Science ®Google Scholar
• Vullo D, De Luca V, Scozzafava A, et al. The first activation study of a bacterial carbonic anhydrase (CA). The thermostable alpha-CA from Sulfurihydrogenibium yellowstonense YO3AOP1 is highly activated by amino acids and amines. Bioorg Med Chem Lett 2012;22:6324-7
   PubMed Web of Science ®Google Scholar
• Vullo D, De Luca V, Scozzafava A, et al. Anion inhibition studies of the fastest carbonic anhydrase (CA) known, the extremo-CA from the bacterium Sulfurihydrogenibium azorense. Bioorg Med Chem Lett 2012;22:7142-5
   PubMed Web of Science ®Google Scholar
• Del Prete S, Isik S, Vullo D, et al. DNA cloning, characterization, and inhibition studies of an alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. J Med Chem 2012;55:10742-8
   PubMed Web of Science ®Google Scholar
• De Luca V, Vullo D, Scozzafava A, et al. Anion inhibition studies of an alpha-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1. Bioorg Med Chem Lett 2012;22:5630-4
   PubMed Web of Science ®Google Scholar
• Aksu K, Nar M, Tanc M, et al. Synthesis and carbonic anhydrase inhibitory properties of sulfamides structurally related to dopamine. Bioorg Med Chem 2013;21:2925-31
   PubMed Web of Science ®Google Scholar
• De Simone G, Alterio V, Supuran CT. Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors. Expert Opin Drug Discov 2013;8:793-810
   PubMed Web of Science ®Google Scholar
• Supuran CT. Structure-based drug discovery of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2012;27:759-72
   PubMed Web of Science ®Google Scholar
• Del Prete S, Vullo D, Fisher GM, et al. Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum-The eta-carbonic anhydrases. Bioorg Med Chem Lett 2014;24:4389-96
   PubMed Web of Science ®Google Scholar
• Vullo D, Del Prete S, Osman SM, et al. Sulfonamide inhibition studies of the delta-carbonic anhydrase from the diatom Thalassiosira weissflogii. Bioorg Med Chem Lett 2014;24:275-9
   PubMed Web of Science ®Google Scholar
• Del Prete S, Vullo D, Scozzafava A, et al. Cloning, characterization and anion inhibition study of the delta-class carbonic anhydrase (TweCA) from the marine diatom Thalassiosira weissflogii. Bioorg Med Chem 2014;22:531-7
   PubMed Web of Science ®Google Scholar
• Capasso C, Supuran CT. Anti-infective carbonic anhydrase inhibitors: a patent and literature review. Expert Opin Ther Pat 2013;23:693-704
   PubMed Web of Science ®Google Scholar
• Vullo D, Kupriyanova EV, Scozzafava A, et al. Anion inhibition study of the beta-carbonic anhydrase (CahB1) from the cyanobacterium Coleofasciculus chthonoplastes (ex-Microcoleus chthonoplastes). Bioorg Med Chem 2014;22:1667-71
   PubMed Web of Science ®Google Scholar
• Vullo D, Flemetakis E, Scozzafava A, et al. Anion inhibition studies of two alpha-carbonic anhydrases from Lotus japonicus, LjCAA1 and LjCAA2. J Inorg Biochem 2014;136:67-72
   PubMed Web of Science ®Google Scholar
• Vullo D, Del Prete S, Osman SM, et al. Anion inhibition study of the beta-class carbonic anhydrase (PgiCAb) from the oral pathogen Porphyromonas gingivalis. Bioorg Med Chem Lett 2014;24:4402-6
   PubMed Web of Science ®Google Scholar
• Rodrigues GC, Feijo DF, Bozza MT, et al. Design, synthesis, and evaluation of hydroxamic acid derivatives as promising agents for the management of Chagas disease. J Med Chem 2014;57:298-308
   PubMed Web of Science ®Google Scholar
• Prete SD, Vullo D, Osman SM, et al. Sulfonamide inhibition study of the carbonic anhydrases from the bacterial pathogen Porphyromonas gingivalis: the beta-class (PgiCAb) versus the gamma-class (PgiCA) enzymes. Bioorg Med Chem 2014;22:4537-43
   PubMed Web of Science ®Google Scholar
• Nishimori I, Vullo D, Minakuchi T, et al. Sulfonamide inhibition studies of two beta-carbonic anhydrases from the bacterial pathogen Legionella pneumophila. Bioorg Med Chem 2014;22:2939-46
   PubMed Web of Science ®Google Scholar
• Migliardini F, De Luca V, Carginale V, et al. Biomimetic CO2 capture using a highly thermostable bacterial alpha-carbonic anhydrase immobilized on a polyurethane foam. J Enzyme Inhib Med Chem 2014;29:146-50
   PubMed Web of Science ®Google Scholar
• Del Prete S, Vullo D, De Luca V, et al. Biochemical characterization of recombinant beta-carbonic anhydrase (PgiCAb) identified in the genome of the oral pathogenic bacterium Porphyromonas gingivalis. J Enzyme Inhib Med Chem 2014. [Epub ahead of print]
   Web of Science ®Google Scholar
• Del Prete S, De Luca V, Vullo D, et al. Biochemical characterization of the gamma-carbonic anhydrase from the oral pathogen Porphyromonas gingivalis, PgiCA. J Enzyme Inhib Med Chem 2014;29:532-7
   PubMed Web of Science ®Google Scholar
• Del Prete S, Vullo D, Fisher GM, et al. Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum--the eta-carbonic anhydrases. Bioorg Med Chem Lett 2014;24:4389-96
   PubMed Web of Science ®Google Scholar
• De Luca V, Del Prete S, Supuran CT, et al. Protonography, a new technique for the analysis of carbonic anhydrase activity. J Enzyme Inhib Med Chem 2015;30(2):277-82
   PubMed Web of Science ®Google Scholar
• Ceruso M, Del Prete S, AlOthman Z, et al. Synthesis of sulfonamides with effective inhibitory action against Porphyromonas gingivalis gamma-carbonic anhydrase. Bioorg Med Chem Lett 2014;24:4006-10
   PubMed Web of Science ®Google Scholar
• Lehneck R, Neumann P, Vullo D, et al. Crystal structures of two tetrameric beta-carbonic anhydrases from the filamentous ascomycete Sordaria macrospora. FEBS J 2014;281(7):1759-72
   PubMed Web of Science ®Google Scholar
• Di Fiore A, Truppo E, Supuran CT, et al. Crystal structure of the C183S/C217S mutant of human CA VII in complex with acetazolamide. Bioorg Med Chem Lett 2010;20:5023-6
   PubMed Web of Science ®Google Scholar
• Avvaru BS, Wagner JM, Maresca A, et al. Carbonic anhydrase inhibitors. The X-ray crystal structure of human isoform II in adduct with an adamantyl analogue of acetazolamide resides in a less utilized binding pocket than most hydrophobic inhibitors. Bioorg Med Chem Lett 2010;20:4376-81
   PubMed Web of Science ®Google Scholar
• Temperini C, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. X-ray crystal studies of the carbonic anhydrase II-trithiocarbonate adduct--an inhibitor mimicking the sulfonamide and urea binding to the enzyme. Bioorg Med Chem Lett 2010;20:474-8
   PubMed Web of Science ®Google Scholar
• Alterio V, Hilvo M, Di Fiore A, et al. Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX. Proc Natl Acad Sci USA 2009;106:16233-8
   PubMed Web of Science ®Google Scholar
• Di Fiore A, Monti SM, Hilvo M, et al. Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide. Proteins 2009;74:164-75
   PubMed Web of Science ®Google Scholar
• Temperini C, Scozzafava A, Puccetti L, et al. Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators. Bioorg Med Chem Lett 2005;15:5136-41
   PubMed Web of Science ®Google Scholar
• Guzel O, Innocenti A, Vullo D, et al. 3-phenyl-1H-indole-5-sulfonamides: structure-based drug design of a promising class of carbonic anhydrase inhibitors. Curr Pharm Des 2010;16:3317-26
   PubMed Web of Science ®Google Scholar
• Temperini C, Innocenti A, Guerri A, et al. Phosph(on)ate as a zinc-binding group in metalloenzyme inhibitors: X-ray crystal structure of the antiviral drug foscarnet complexed to human carbonic anhydrase I. Bioorg Med Chem Lett 2007;17:2210-15
   PubMed Web of Science ®Google Scholar
• Winum JY, Temperini C, El Cheikh K, et al. Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue. J Med Chem 2006;49:7024-31
   PubMed Web of Science ®Google Scholar
• De Simone G, Di Fiore A, Capasso C, et al. The zinc coordination pattern in the η-carbonic anhydrase from Plasmodium falciparum is different from all other carbonic anhydrase genetic families. Bioorg Med Chem Lett 2015;25:1385-9
   PubMed Web of Science ®Google Scholar
• Sacarlal J, Nhacolo AQ, Sigauque B, et al. A 10 year study of the cause of death in children under 15 years in Manhica, Mozambique. BMC Public Health 2009;9:67
   PubMed Web of Science ®Google Scholar
• Gaynor M, Mankin AS. Macrolide antibiotics: binding site, mechanism of action, resistance. Curr Top Med Chem 2003;3:949-61
   PubMed Web of Science ®Google Scholar
• Rusconi S, Scozzafava A, Mastrolorenzo A, et al. New advances in HIV entry inhibitors development. Curr Drug Targets Infect Disord 2004;4:339-55
   PubMedGoogle Scholar
• Innocenti A, Hall RA, Schlicker C, et al. Carbonic anhydrase inhibitors. Inhibition and homology modeling studies of the fungal beta-carbonic anhydrase from Candida albicans with sulfonamides. Bioorg Med Chem 2009;17:4503-9
   PubMed Web of Science ®Google Scholar
• Maresca A, Scozzafava A, Kohler S, et al. Inhibition of beta-carbonic anhydrases from the bacterial pathogen Brucella suis with inorganic anions. J Inorg Biochem 2012;110:36-9
   PubMed Web of Science ®Google Scholar
• Supuran CT. Inhibition of bacterial carbonic anhydrases and zinc proteases: from orphan targets to innovative new antibiotic drugs. Curr Med Chem 2012;19:831-44
   PubMed Web of Science ®Google Scholar
• Bertucci A, Innocenti A, Scozzafava A, et al. Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata. Bioorg Med Chem Lett 2011;21:710-14
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2010;20:3467-74
   PubMed Web of Science ®Google Scholar
• Sulek K. [Nobel prize for Gerhard Domagk in 1939 for discovery of the antibacterial activity of prontosil]. Wiad Lek 1968;21:1089
   PubMedGoogle Scholar
• Supuran CT. Bacterial carbonic anhydrases as drug targets: toward novel antibiotics? Front Pharmacol 2011;2:34
   PubMed Web of Science ®Google Scholar
• Vullo D, Nishimori I, Minakuchi T, et al. Inhibition studies with anions and small molecules of two novel beta-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium. Bioorg Med Chem Lett 2011;21:3591-5
   PubMed Web of Science ®Google Scholar
• Del Prete S, Vullo D, Scozzafava A, et al. Cloning, characterization and anion inhibition study of the delta-class carbonic anhydrase (TweCA) from the marine diatom Thalassiosira weissflogii. Bioorg Med Chem 2014;22(1):531-7
   PubMed Web of Science ®Google Scholar
• Vullo D, Luca VD, Scozzafava A, et al. The alpha-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1 is highly susceptible to inhibition by sulfonamides. Bioorg Med Chem 2013;21(6):1534-8
   PubMed Web of Science ®Google Scholar
• Luca VD, Vullo D, Scozzafava A, et al. An alpha-carbonic anhydrase from the thermophilic bacterium Sulphurihydrogenibium azorense is the fastest enzyme known for the CO(2) hydration reaction. Bioorg Med Chem 2013;21(6):1465-9
   PubMed Web of Science ®Google Scholar
• Akdemir A, Vullo D, Luca VD, et al. The extremo-alpha-carbonic anhydrase (CA) from Sulfurihydrogenibium azorense, the fastest CA known, is highly activated by amino acids and amines. Bioorg Med Chem Lett 2013;23(4):1087-90
   PubMed Web of Science ®Google Scholar
• Carta F, Aggarwal M, Maresca A, et al. Dithiocarbamates strongly inhibit carbonic anhydrases and show antiglaucoma action in vivo. J Med Chem 2012;55:1721-30
   PubMed Web of Science ®Google Scholar
• Carta F, Aggarwal M, Maresca A, et al. Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations. Chem Commun (Camb) 2012;48:1868-70
   PubMed Web of Science ®Google Scholar
• Monti SM, Maresca A, Viparelli F, et al. Dithiocarbamates are strong inhibitors of the beta-class fungal carbonic anhydrases from Cryptococcus neoformans, Candida albicans and Candida glabrata. Bioorg Med Chem Lett 2012;22:859-62
   PubMed Web of Science ®Google Scholar
• Maresca A, Carta F, Vullo D, et al. Dithiocarbamates strongly inhibit the beta-class carbonic anhydrases from Mycobacterium tuberculosis. J Enzyme Inhib Med Chem 2013;28:407-11
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Mastrolorenzo A, Supuran CT. Arylsulfonyl-N,N-dialkyl-dithiocarbamates as tumor cell growth inhibitors: novel agents targeting beta-tubulin? J Enzyme Inhib 2001;16:55-63
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Mastrolorenzo A, Supuran CT. Arylsulfonyl-N,N-diethyl-dithiocarbamates: a novel class of antitumor agents. Bioorg Med Chem Lett 2000;10:1887-91
   PubMed Web of Science ®Google Scholar
• Innocenti A, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of transmembrane isoforms IX, XII, and XIV with less investigated anions including trithiocarbonate and dithiocarbamate. Bioorg Med Chem Lett 2010;20:1548-50
   PubMed Web of Science ®Google Scholar
• McKenna R, Supuran CT. Carbonic anhydrase inhibitors drug design. Subcell Biochem 2014;75:291-323
   PubMedGoogle Scholar
• Adak AK, Leonov AP, Ding N, et al. Bishydrazide glycoconjugates for lectin recognition and capture of bacterial pathogens. Bioconjug Chem 2010;21:2065-75
   PubMed Web of Science ®Google Scholar
• Smith KS, Ferry JG. Prokaryotic carbonic anhydrases. FEMS Microbiol Rev 2000;24:335-66
   PubMed Web of Science ®Google Scholar
• Maeda S, Price GD, Badger MR, et al. Bicarbonate binding activity of the CmpA protein of the cyanobacterium Synechococcus sp. strain PCC 7942 involved in active transport of bicarbonate. J Biol Chem 2000;275:20551-5
   PubMed Web of Science ®Google Scholar
• Joseph P, Ouahrani-Bettache S, Montero JL, et al. A new beta-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth. Bioorg Med Chem 2011;19:1172-8
   PubMed Web of Science ®Google Scholar
• Joseph P, Turtaut F, Ouahrani-Bettache S, et al. Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis. J Med Chem 2010;53:2277-85
   PubMed Web of Science ®Google Scholar
• Adler L, Brundell J, Falkbring SO, et al. Carbonic anhydrase from Neisseria sicca, strain 6021. I. Bacterial growth and purification of the enzyme. Biochim Biophys Acta 1972;284:298-310
   PubMed Web of Science ®Google Scholar
• Chirica LC, Elleby B, Jonsson BH, et al. The complete sequence, expression in Escherichia coli, purification and some properties of carbonic anhydrase from Neisseria gonorrhoeae. Eur J Biochem 1997;244:755-60
   PubMedGoogle Scholar
• Chirica LC, Petersson C, Hurtig M, et al. Expression and localization of alpha- and beta-carbonic anhydrase in Helicobacter pylori. Biochim Biophys Acta 2002;1601:192-9
   PubMed Web of Science ®Google Scholar
• Guilloton MB, Korte JJ, Lamblin AF, et al. Carbonic anhydrase in Escherichia coli. A product of the cyn operon. J Biol Chem 1992;267:3731-4
   PubMed Web of Science ®Google Scholar
• Nishimori I, Minakuchi T, Morimoto K, et al. Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs. J Med Chem 2006;49:2117-26
   PubMed Web of Science ®Google Scholar
• Nishimori I, Onishi S, Takeuchi H, et al. The alpha and beta classes carbonic anhydrases from Helicobacter pylori as novel drug targets. Curr Pharm Des 2008;14:622-30
   PubMed Web of Science ®Google Scholar
• Shahidzadeh R, Opekun A, Shiotani A, et al. Effect of the carbonic anhydrase inhibitor, acetazolamide, on Helicobacter pylori infection in vivo: a pilot study. Helicobacter 2005;10:136-8
   PubMed Web of Science ®Google Scholar
• Nishimori I, Vullo D, Minakuchi T, et al. Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori. Bioorg Med Chem Lett 2006;16:2182-8
   PubMed Web of Science ®Google Scholar
• Nishimori I, Minakuchi T, Kohsaki T, et al. Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors. Bioorg Med Chem Lett 2007;17:3585-94
   PubMed Web of Science ®Google Scholar
• Morishita S, Nishimori I, Minakuchi T, et al. Cloning, polymorphism, and inhibition of beta-carbonic anhydrase of Helicobacter pylori. J Gastroenterol 2008;43:849-57
   PubMed Web of Science ®Google Scholar
• Vullo D, Isik S, Del Prete S, et al. Anion inhibition studies of the alpha-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae. Bioorg Med Chem Lett 2013;23:1636-8
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibition/activation: trip of a scientist around the world in the search of novel chemotypes and drug targets. Curr Pharm Des 2010;16:3233-45
   PubMed Web of Science ®Google Scholar
• Buchieri MV, Riafrecha LE, Rodriguez OM, et al. Inhibition of the beta-carbonic anhydrases from Mycobacterium tuberculosis with C-cinnamoyl glycosides: identification of the first inhibitor with anti-mycobacterial activity. Bioorg Med Chem Lett 2013;23:740-3
   PubMed Web of Science ®Google Scholar
• Burghout P, Vullo D, Scozzafava A, et al. Inhibition of the beta-carbonic anhydrase from Streptococcus pneumoniae by inorganic anions and small molecules: Toward innovative drug design of antiinfectives? Bioorg Med Chem 2011;19:243-8
   PubMed Web of Science ®Google Scholar
• Cronk JD, O’Neill JW, Cronk MR, et al. Cloning, crystallization and preliminary characterization of a beta-carbonic anhydrase from Escherichia coli. Acta Crystallogr D Biol Crystallogr 2000;56:1176-9
   PubMed Web of Science ®Google Scholar
• Guzel O, Maresca A, Scozzafava A, et al. Discovery of low nanomolar and subnanomolar inhibitors of the mycobacterial beta-carbonic anhydrases Rv1284 and Rv3273. J Med Chem 2009;52:4063-7
   PubMed Web of Science ®Google Scholar
• Nishimori I, Minakuchi T, Maresca A, et al. The beta-carbonic anhydrases from Mycobacterium tuberculosis as drug targets. Curr Pharm Des 2010;16:3300-9
   PubMed Web of Science ®Google Scholar
• Nishimori I, Minakuchi T, Vullo D, et al. Inhibition studies of the beta-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates. Bioorg Med Chem 2011;19:5023-30
   PubMed Web of Science ®Google Scholar
• Cronk JD, Rowlett RS, Zhang KY, et al. Identification of a novel noncatalytic bicarbonate binding site in eubacterial beta-carbonic anhydrase. Biochemistry 2006;45:4351-61
   PubMed Web of Science ®Google Scholar
• Suarez Covarrubias A, Larsson AM, Hogbom M, et al. Structure and function of carbonic anhydrases from Mycobacterium tuberculosis. J Biol Chem 2005;280:18782-9
   PubMed Web of Science ®Google Scholar
• Suarez M, Haenni M, Canarelli S, et al. Structure-function characterization and optimization of a plant-derived antibacterial peptide. Antimicrob Agents Chemother 2005;49:3847-57
   PubMed Web of Science ®Google Scholar
• Carta F, Maresca A, Covarrubias AS, et al. Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c. Bioorg Med Chem Lett 2009;19:6649-54
   PubMed Web of Science ®Google Scholar
• Minakuchi T, Nishimori I, Vullo D, et al. Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate. J Med Chem 2009;52:2226-32
   PubMed Web of Science ®Google Scholar
• Nishimori I, Minakuchi T, Onishi S, et al. Carbonic anhydrase inhibitors. Cloning, characterization and inhibition studies of the cytosolic isozyme III with anions. J Enzyme Inhib Med Chem 2009;24:70-6
   PubMed Web of Science ®Google Scholar
• Vullo D, Nishimori I, Scozzafava A, et al. Inhibition studies of a beta-carbonic anhydrase from Brucella suis with a series of water soluble glycosyl sulfanilamides. Bioorg Med Chem Lett 2010;20:2178-82
   PubMed Web of Science ®Google Scholar
• Alber BE, Ferry JG. A carbonic anhydrase from the archaeon Methanosarcina thermophila. Proc Natl Acad Sci USA 1994;91:6909-13
   PubMed Web of Science ®Google Scholar
• Guzel O, Innocenti A, Hall RA, et al. Carbonic anhydrase inhibitors. The nematode alpha-carbonic anhydrase of Caenorhabditis elegans CAH-4b is highly inhibited by 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides. Bioorg Med Chem 2009;17:3212-15
   PubMed Web of Science ®Google Scholar
• Crocetti L, Maresca A, Temperini C, et al. A thiabendazole sulfonamide shows potent inhibitory activity against mammalian and nematode alpha-carbonic anhydrases. Bioorg Med Chem Lett 2009;19:1371-5
   PubMed Web of Science ®Google Scholar
• Riafrecha LE, Vullo D, Supuran CT, et al. C-glycosides incorporating the 6-methoxy-2-naphthyl moiety are selective inhibitors of fungal and bacterial carbonic anhydrases. J Enzyme Inhib Med Chem 2014; Epub ahead of print
   PubMed Web of Science ®Google Scholar
• Sechi M, Innocenti A, Pala N, et al. Inhibition of alpha-class cytosolic human carbonic anhydrases I, II, IX and XII, and beta-class fungal enzymes by carboxylic acids and their derivatives: new isoform-I selective nanomolar inhibitors. Bioorg Med Chem Lett 2012;22:5801-6
   PubMed Web of Science ®Google Scholar
• Cottier F, Leewattanapasuk W, Kemp LR, et al. Carbonic anhydrase regulation and CO(2) sensing in the fungal pathogen Candida glabrata involves a novel Rca1p ortholog. Bioorg Med Chem 2013;21:1549-54
   PubMed Web of Science ®Google Scholar
• Rami M, Innocenti A, Montero JL, et al. Synthesis of rhodamine B-benzenesulfonamide conjugates and their inhibitory activity against human alpha- and bacterial/fungal beta-carbonic anhydrases. Bioorg Med Chem Lett 2011;21:5210-13
   PubMed Web of Science ®Google Scholar
• Carta F, Innocenti A, Hall RA, et al. Carbonic anhydrase inhibitors. Inhibition of the beta-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with branched aliphatic/aromatic carboxylates and their derivatives. Bioorg Med Chem Lett 2011;21:2521-6
   PubMed Web of Science ®Google Scholar
• Davis RA, Hofmann A, Osman A, et al. Natural product-based phenols as novel probes for mycobacterial and fungal carbonic anhydrases. J Med Chem 2011;54:1682-92
   PubMed Web of Science ®Google Scholar
• Guzel O, Maresca A, Hall RA, et al. Carbonic anhydrase inhibitors. The beta-carbonic anhydrases from the fungal pathogens Cryptococcus neoformans and Candida albicans are strongly inhibited by substituted-phenyl-1H-indole-5-sulfonamides. Bioorg Med Chem Lett 2010;20:2508-11
   PubMed Web of Science ®Google Scholar
• Innocenti A, Winum JY, Hall RA, et al. Carbonic anhydrase inhibitors. Inhibition of the fungal beta-carbonic anhydrases from Candida albicans and Cryptococcus neoformans with boronic acids. Bioorg Med Chem Lett 2009;19:2642-5
   PubMed Web of Science ®Google Scholar
• Innocenti A, Hall RA, Schlicker C, et al. Carbonic anhydrase inhibitors. Inhibition of the beta-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with aliphatic and aromatic carboxylates. Bioorg Med Chem 2009;17:2654-7
   PubMed Web of Science ®Google Scholar
• Innocenti A, Muhlschlegel FA, Hall RA, et al. Carbonic anhydrase inhibitors: inhibition of the beta-class enzymes from the fungal pathogens Candida albicans and Cryptococcus neoformans with simple anions. Bioorg Med Chem Lett 2008;18:5066-70
   PubMed Web of Science ®Google Scholar
• Vullo D, Leewattanapasuk W, Muhlschlegel FA, et al. Carbonic anhydrase inhibitors: inhibition of the beta-class enzyme from the pathogenic yeast Candida glabrata with sulfonamides, sulfamates and sulfamides. Bioorg Med Chem Lett 2013;23:2647-52
   PubMed Web of Science ®Google Scholar
• Innocenti A, Leewattanapasuk W, Manole G, et al. Carbonic anhydrase activators: Activation of the beta-carbonic anhydrase from the pathogenic yeast Candida glabrata with amines and amino acids. Bioorg Med Chem Lett 2010;20:1701-4
   PubMed Web of Science ®Google Scholar
• Innocenti A, Leewattanapasuk W, Muhlschlegel FA, et al. Carbonic anhydrase inhibitors. Inhibition of the beta-class enzyme from the pathogenic yeast Candida glabrata with anions. Bioorg Med Chem Lett 2009;19:4802-5
   PubMed Web of Science ®Google Scholar
• Isik S, Kockar F, Aydin M, et al. Carbonic anhydrase activators: activation of the beta-carbonic anhydrase Nce103 from the yeast Saccharomyces cerevisiae with amines and amino acids. Bioorg Med Chem Lett 2009;19:1662-5
   PubMed Web of Science ®Google Scholar
• Isik S, Kockar F, Aydin M, et al. Carbonic anhydrase inhibitors: inhibition of the beta-class enzyme from the yeast Saccharomyces cerevisiae with sulfonamides and sulfamates. Bioorg Med Chem 2009;17:1158-63
   PubMed Web of Science ®Google Scholar
• Isik S, Kockar F, Arslan O, et al. Carbonic anhydrase inhibitors. Inhibition of the beta-class enzyme from the yeast Saccharomyces cerevisiae with anions. Bioorg Med Chem Lett 2008;18:6327-31
   PubMed Web of Science ®Google Scholar
• Carta F, Garaj V, Maresca A, et al. Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies. Bioorg Med Chem 2011;19:3105-19
   PubMed Web of Science ®Google Scholar
• Schlicker C, Hall RA, Vullo D, et al. Structure and inhibition of the CO2-sensing carbonic anhydrase Can2 from the pathogenic fungus Cryptococcus neoformans. J Mol Biol 2009;385:1207-20
   PubMed Web of Science ®Google Scholar
• Hewitson KS, Vullo D, Scozzafava A, et al. Molecular cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Malassezia globosa, a potential antidandruff target. J Med Chem 2012;55:3513-20
   PubMed Web of Science ®Google Scholar
• Elleuche S, Poggeler S. Beta-carbonic anhydrases play a role in fruiting body development and ascospore germination in the filamentous fungus Sordaria macrospora. PLoS ONE 2009;4:e5177
   PubMed Web of Science ®Google Scholar
• Lehneck R, Elleuche S, Poggeler S. The filamentous ascomycete Sordaria macrospora can survive in ambient air without carbonic anhydrases. Mol Microbiol 2014;92:931-44
   PubMed Web of Science ®Google Scholar
• Lehneck R, Poggeler S. A matter of structure: structural comparison of fungal carbonic anhydrases. Appl Microbiol Biotechnol 2014;98:8433-41
   PubMed Web of Science ®Google Scholar
• Elleuche S, Poggeler S. Carbonic anhydrases in fungi. Microbiology 2010;156:23-9
   PubMed Web of Science ®Google Scholar
• Krungkrai J, Krungkrai SR, Supuran CT. Carbonic anhydrase inhibitors: inhibition of Plasmodium falciparum carbonic anhydrase with aromatic/heterocyclic sulfonamides-in vitro and in vivo studies. Bioorg Med Chem Lett 2008;18:5466-71
   PubMed Web of Science ®Google Scholar
• Krungkrai J, Scozzafava A, Reungprapavut S, et al. Carbonic anhydrase inhibitors. Inhibition of Plasmodium falciparum carbonic anhydrase with aromatic sulfonamides: towards antimalarials with a novel mechanism of action? Bioorg Med Chem 2005;13:483-9
   PubMed Web of Science ®Google Scholar
• Reungprapavut S, Krungkrai SR, Krungkrai J. Plasmodium falciparum carbonic anhydrase is a possible target for malaria chemotherapy. J Enzyme Inhib Med Chem 2004;19:249-56
   PubMed Web of Science ®Google Scholar
• Krungkrai SR, Suraveratum N, Rochanakij S, et al. Characterisation of carbonic anhydrase in Plasmodium falciparum. Int J Parasitol 2001;31:661-8
   PubMed Web of Science ®Google Scholar
• Vullo D, Del Prete S, Fisher GM, et al. Sulfonamide inhibition studies of the eta-class carbonic anhydrase from the malaria pathogen Plasmodium falciparum. Bioorg Med Chem 2015;23(3):526-31
   PubMed Web of Science ®Google Scholar
• Supuran CT, Capasso C. The eta-class carbonic anhydrases as drug targets for antimalarial agents. Expert Opin Ther Targets 2015;19(4):551-63
   PubMed Web of Science ®Google Scholar
• De Simone G, Supuran CT. (In)organic anions as carbonic anhydrase inhibitors. J Inorg Biochem 2012;111:117-29
   PubMed Web of Science ®Google Scholar
• Supuran CT, Di Fiore A, Alterio V, et al. Recent advances in structural studies of the carbonic anhydrase family: the crystal structure of human CA IX and CA XIII. Curr Pharm Des 2010;16:3246-54
   PubMed Web of Science ®Google Scholar
• De Simone G, Supuran CT. Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target. Biochim Biophys Acta 2010;1804:404-9
   PubMed Web of Science ®Google Scholar
• De Simone G, Di Fiore A, Supuran CT. Are carbonic anhydrase inhibitors suitable for obtaining antiobesity drugs? Curr Pharm Des 2008;14:655-60
   PubMed Web of Science ®Google Scholar
• Winum JY, Supuran CT. Recent advances in the discovery of zinc-binding motifs for the development of carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 2015;30(2):321-4
   PubMed Web of Science ®Google Scholar
• Pan P, Vermelho AB, Capaci Rodrigues G, et al. Cloning, characterization, and sulfonamide and thiol inhibition studies of an alpha-carbonic anhydrase from Trypanosoma cruzi, the causative agent of Chagas disease. J Med Chem 2013;56:1761-71
   PubMed Web of Science ®Google Scholar
• Guzel-Akdemir O, Akdemir A, Pan P, et al. A class of sulfonamides with strong inhibitory action against the alpha-carbonic anhydrase from Trypanosoma cruzi. J Med Chem 2013;56:5773-81
   PubMed Web of Science ®Google Scholar
• Von Stebut E. Leishmaniasis. J Dtsch Dermatol Ges 2015;13:191-201
   PubMedGoogle Scholar
• Syrjanen L, Vermelho AB, Rodrigues Ide A, et al. Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Leishmania donovani chagasi, the protozoan parasite responsible for leishmaniasis. J Med Chem 2013;56:7372-81
   PubMed Web of Science ®Google Scholar
• Puscas I. Treatment of gastroduodenal ulcers with carbonic anhydrase inhibitors. Ann NY Acad Sci 1984;429:587-91
   PubMed Web of Science ®Google Scholar
• Modakh JK, Liu YC, Machuca MA, et al. Structural basis for the inhibition of Helicobacter pylori α-carbonic anhydrase by sulfonamides. PLoS One 2015;10:e0127149
   PubMed Web of Science ®Google Scholar
• Supuran CT, Clare BW. Carbonic anhydrase inhibitors–Part 57: Quantum chemical QSAR of a group of 1, 3, 4-thiadiazole-and 1, 3, 4-thiadiazoline disulfonamides with carbonic anhydrase inhibitory properties. Eur J Med Chem 1999;34:41-50
   Web of Science ®Google Scholar
• Briganti F, Pierattelli R, Supuran CT, et al. Carbonic anhydrase inhibitors. Part 37. Novel classes of isozyme I and II inhibitors and their mechanism of action. Kinetic and spectroscopic investigations on native and cobalt-substituted enzymes. Eur J Med Chem 1996;31:439-47
   Web of Science ®Google Scholar
• Vullo D, Del Prete S, Fisher GM, et al. Sulfonamide inhibition studies of the eta-class carbonic anhydrase from the malaria pathogen Plasmodium falciparum. Bioorg Med Chem 2015;23:526-31
   PubMed Web of Science ®Google Scholar